These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 7598747)

  • 1. Allosteric regulation of [3H]vinblastine binding to P-glycoprotein of MCF-7 ADR cells by dexniguldipine.
    Ferry DR; Malkhandi PJ; Russell MA; Kerr DJ
    Biochem Pharmacol; 1995 Jun; 49(12):1851-61. PubMed ID: 7598747
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dexniguldipine-HCl is a potent allosteric inhibitor of [3H]vinblastine binding to P-glycoprotein of CCRF ADR 5000 cells.
    Malkhandi J; Ferry DR; Boer R; Gekeler V; Ise W; Kerr DJ
    Eur J Pharmacol; 1994 Dec; 288(1):105-14. PubMed ID: 7705462
    [TBL] [Abstract][Full Text] [Related]  

  • 3. P-glycoprotein possesses a 1,4-dihydropyridine-selective drug acceptor site which is alloserically coupled to a vinca-alkaloid-selective binding site.
    Ferry DR; Russell MA; Cullen MH
    Biochem Biophys Res Commun; 1992 Oct; 188(1):440-5. PubMed ID: 1358068
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Localization of the 1,4-dihydropyridine drug acceptor of P-glycoprotein to a cytoplasmic domain using a permanently charged derivative N-methyl dexniguldipine.
    Ferry D; Boer R; Callaghan R; Ulrich WR
    Int J Clin Pharmacol Ther; 2000 Mar; 38(3):130-40. PubMed ID: 10739116
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of P-glycoprotein activity by estramustine is limited by binding to plasma proteins.
    Smith CD; Zilfou JT; Zhang X; Hudes GR; Tew KD
    Cancer; 1995 May; 75(10):2597-604. PubMed ID: 7736407
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multidrug resistance transporter P-glycoprotein has distinct but interacting binding sites for cytotoxic drugs and reversing agents.
    Pascaud C; Garrigos M; Orlowski S
    Biochem J; 1998 Jul; 333 ( Pt 2)(Pt 2):351-8. PubMed ID: 9657975
    [TBL] [Abstract][Full Text] [Related]  

  • 7. B9209-005, an azido derivative of the chemosensitizer dexniguldipine-HCl, photolabels P-glycoprotein.
    Borchers C; Ulrich WR; Klemm K; Ise W; Gekeler V; Haas S; Schödl A; Conrad J; Przybylski M; Boer R
    Mol Pharmacol; 1995 Jul; 48(1):21-9. PubMed ID: 7623771
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction of cytostatics and chemosensitizers with the dexniguldipine binding site on P-glycoprotein.
    Boer R; Ulrich WR; Haas S; Borchers C; Gekeler V; Boss H; Przybylski M; Schödl A
    Eur J Pharmacol; 1996 Jan; 295(2-3):253-60. PubMed ID: 8720592
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of the dexniguldipine binding site in the multidrug resistance-related transport protein P-glycoprotein by photoaffinity labeling and mass spectrometry.
    Borchers C; Boer R; Klemm K; Figala V; Denzinger T; Ulrich WR; Haas S; Ise W; Gekeler V; Przybylski M
    Mol Pharmacol; 2002 Jun; 61(6):1366-76. PubMed ID: 12021398
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Agents which reverse multidrug-resistance are inhibitors of [3H]vinblastine transport by isolated vesicles.
    Horio M; Lovelace E; Pastan I; Gottesman MM
    Biochim Biophys Acta; 1991 Jan; 1061(1):106-10. PubMed ID: 1671642
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional studies of P-glycoprotein in inside-out plasma membrane vesicles derived from murine erythroleukemia cells overexpressing MDR 3. Properties and kinetics of the interaction of vinblastine with P-glycoprotein and evidence for its active mediated transport.
    Schlemmer SR; Sirotnak FM
    J Biol Chem; 1994 Dec; 269(49):31059-66. PubMed ID: 7983045
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Partial inhibition of multidrug resistance by safingol is independent of modulation of P-glycoprotein substrate activities and correlated with inhibition of protein kinase C.
    Sachs CW; Safa AR; Harrison SD; Fine RL
    J Biol Chem; 1995 Nov; 270(44):26639-48. PubMed ID: 7592889
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of staurosporine and four analogues: their effects on growth, rhodamine 123 retention and binding to P-glycoprotein in multidrug-resistant MCF-7/Adr cells.
    Budworth J; Davies R; Malkhandi J; Gant TW; Ferry DR; Gescher A
    Br J Cancer; 1996 May; 73(9):1063-8. PubMed ID: 8624264
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Azidopine noncompetitively interacts with vinblastine and cyclosporin A binding to P-glycoprotein in multidrug resistant cells.
    Tamai I; Safa AR
    J Biol Chem; 1991 Sep; 266(25):16796-800. PubMed ID: 1679434
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Competitive and non-competitive inhibition of the multidrug-resistance-associated P-glycoprotein ATPase--further experimental evidence for a multisite model.
    Garrigos M; Mir LM; Orlowski S
    Eur J Biochem; 1997 Mar; 244(2):664-73. PubMed ID: 9119038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanism of action of dexniguldipine-HCl (B8509-035), a new potent modulator of multidrug resistance.
    Hofmann J; Gekeler V; Ise W; Noller A; Mitterdorfer J; Hofer S; Utz I; Gotwald M; Boer R; Glossmann H
    Biochem Pharmacol; 1995 Mar; 49(5):603-9. PubMed ID: 7887974
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The multi-drug resistance reversal agent SR33557 and modulation of vinca alkaloid binding to P-glycoprotein by an allosteric interaction.
    Martin C; Berridge G; Higgins CF; Callaghan R
    Br J Pharmacol; 1997 Oct; 122(4):765-71. PubMed ID: 9375975
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction of tamoxifen with the multidrug resistance P-glycoprotein.
    Callaghan R; Higgins CF
    Br J Cancer; 1995 Feb; 71(2):294-9. PubMed ID: 7841043
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Indoloquinoxaline compounds that selectively antagonize P-glycoprotein.
    Smith CD; Myers CB; Zilfou JT; Smith SN; Lawrence DS
    Oncol Res; 2000; 12(5):219-29. PubMed ID: 11417747
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reversal of P-glycoprotein-associated multidrug resistance by ivermectin.
    Pouliot JF; L'Heureux F; Liu Z; Prichard RK; Georges E
    Biochem Pharmacol; 1997 Jan; 53(1):17-25. PubMed ID: 8960059
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.